Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
ZyVersa Therapeutics (ZVSA)
NASDAQ:ZVSA
RESEARCH TOOLSreports
Holding ZVSA?
Track your performance easily
ZVSA Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$3.41 - $90.96
Previous Close$4.9
Volume109.01K
Average Volume (3M)284.19K
Market Cap
$4.09M
Enterprise Value$961.97K
Total Cash (Recent Filing)$3.14M
Total Debt (Recent Filing)$8.66K
Price to Earnings (P/E)―
Beta1.04
Next Earnings
Aug 19, 2024EPS Estimate
-$2.2Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1764.75
Shares Outstanding834,896
10 Day Avg. Volume45,691
30 Day Avg. Volume284,191
Standard Deviation0.33
R-Squared0.01
Alpha-0.14
Financial Highlights & Ratios
Price to Book (P/B)0.30
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-0.30
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit10.00T>
Enterprise Value/Ebitda-0.01
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
ZyVersa Therapeutics News
PremiumMarket News
3 Penny Stocks to Watch Now, 11/7/24
PremiumCompany Announcements
ZyVersa Therapeutics Reports Q3 Progress and Outlook
PremiumCompany Announcements
ZyVersa Therapeutics’ Shareholder Approvals and Director ElectionsRisk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
ZVSA FAQ
What was ZyVersa Therapeutics’s price range in the past 12 months?
ZyVersa Therapeutics lowest stock price was $3.41 and its highest was $90.96 in the past 12 months.
What is ZyVersa Therapeutics’s market cap?
Currently, no data Available
When is ZyVersa Therapeutics’s upcoming earnings report date?
ZyVersa Therapeutics’s upcoming earnings report date is Aug 19, 2024 which is 97 days ago.
How were ZyVersa Therapeutics’s earnings last quarter?
ZyVersa Therapeutics released its earnings results on May 15, 2024. The company reported -$4.53 earnings per share for the quarter, missing the consensus estimate of -$3.7 by -$0.83.
Is ZyVersa Therapeutics overvalued?
According to Wall Street analysts ZyVersa Therapeutics’s price is currently Overvalued.
Does ZyVersa Therapeutics pay dividends?
ZyVersa Therapeutics does not currently pay dividends.
What is ZyVersa Therapeutics’s EPS estimate?
ZyVersa Therapeutics’s EPS estimate is -$2.2.
How many shares outstanding does ZyVersa Therapeutics have?
ZyVersa Therapeutics has 834,896 shares outstanding.
What happened to ZyVersa Therapeutics’s price movement after its last earnings report?
ZyVersa Therapeutics reported an EPS of -$4.53 in its last earnings report, missing expectations of -$3.7. Following the earnings report the stock price went down -6.616%.
Which hedge fund is a major shareholder of ZyVersa Therapeutics?
Among the largest hedge funds holding ZyVersa Therapeutics’s share is Saba Capital Management. It holds ZyVersa Therapeutics’s shares valued at N/A.
---
ZyVersa Therapeutics Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Hedge Fund Trend
Decreased
By 1.7K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.7%
Last 30 Days ▼ 1.1%
Last 30 Days ▼ 1.1%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-94.50%
12-Months-Change
Fundamentals
Return on Equity
-180.17%
Trailing 12-Months
Asset Growth
-81.17%
Trailing 12-Months
Company Description
ZyVersa Therapeutics
Larkspur Health Acquisition Corp is a blank check company.
---
ZVSA Stock 12 Month Forecast
Average Price Target
―Technical Analysis
Best Analysts Covering ZVSA
1 Year
1 Year Success Rate
0/5 ratings generated profit
1 Year Average Return
-68.40%
reiterated a buy rating 8 months ago
Copying Ed Arce's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -68.40% per trade.
---